医学
磁共振成像
超声波
前列腺
前列腺活检
放射科
活检
内科学
癌症
作者
Rustu Turkay,Ercan Inci,Omer Yildiz,Eren Ozgur,Ali Ihsan Tasci
出处
期刊:Ultrasound Quarterly
[Ovid Technologies (Wolters Kluwer)]
日期:2020-12-01
卷期号:36 (4): 345-349
被引量:1
标识
DOI:10.1097/ruq.0000000000000505
摘要
The aim of our study is to compare 2 prostate fusion biopsy models in terms of accurate target sampling. One hundred patients who had Prostate Imaging-Reporting and Data System score 3, 4, or 5 lesions (lesion diameter, >5 mm in long axis) in multiparametric-magnetic resonance imaging and prostate-specific antigen levels between 3 and 10 ng/mL were enrolled in the study. All patients were biopsy naive. Two groups were composed with 50 patients each. Group 1 patients had cognitive fusion (CF) biopsy, and group 2 had magnetic resonance-ultrasound fusion platform biopsy. After fusion biopsy, standard biopsy was also performed. Outcomes of histopathologic and demographic data were evaluated statistically. There were no statistical differences between the 2 groups in terms of age, prostate-specific antigen levels, prostate volume, and lesion length (P > 0.05). There was no statistically significant difference in sampling targeted lesions (P > 0.05). Also, no difference was found between the 2 groups in terms of random biopsy cancer detection rates (P > 0.05). There was no statistically significant difference between CF and magnetic resonance-ultrasound fusion in terms of cancer detection rates. For the experienced operators, we recommend lesions that are longer than 5 mm can be sampled using CF, an inexpensive and faster technique.
科研通智能强力驱动
Strongly Powered by AbleSci AI